Audit 896

FY End
2023-06-30
Total Expended
$7.19M
Findings
2
Programs
5
Year: 2023 Accepted: 2023-10-20

Organization Exclusion Status:

Checking exclusion status...

Findings

ID Ref Severity Repeat Requirement
425 2023-001 Significant Deficiency Yes AB
576867 2023-001 Significant Deficiency Yes AB

Programs

ALN Program Spent Major Findings
93.498 Provider Relief Fund $4.92M Yes 1
93.870 Maternal, Infant and Early Childhood Home Visiting Grant $861,070 Yes 0
93.778 Medical Assistance Program $776,973 - 0
32.006 Covid-19 Telehealth Program $355,034 - 0
93.253 Poison Center Support and Enhancement Grant $279,035 - 0

Contacts

Name Title Type
TN6UN1R1Y6C3 Dean Cocchi Auditee
9042448675 John Disanto Auditor
No contacts on file

Notes to SEFA

Title: Basis of Presentation Accounting Policies: The information in this Schedule is presented in accordance with the requirements of the Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). De Minimis Rate Used: N Rate Explanation: The auditee did not use the de minimis cost rate. The accompanying Schedule of Expenditures of Federal Awards (the Schedule) includes the federal grant activity of Shands Jacksonville HealthCare, Inc. and Subsidiaries (the Company) and is presented on the accrual basis of accounting. The information in this Schedule is presented in accordance with the requirements of the Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). Because the Schedule presents only a selected portion of the operations of the Company, it is not intended to and does not present the financial position, changes in net position, or cash flows of the Company. The purpose of the Schedule is to present a summary of those activities of the Company for the year ended June 30, 2023, which have been financed by the federal government. For purposes of the Schedule, federal awards include any assistance provided by a federal agency directly or indirectly in the form of grants and contracts. Direct and indirect costs are charged to awards in accordance with cost principles contained in the Department of Health and Human Services, Office of the Assistant Secretary Comptroller (OASC), OASC-3 Hospital Cost Principles (or CFR Part 45, Part 74, Appendix E) and Uniform Guidance, 2 CFR Part 200, Subpart E Cost Principles. Under these cost principles, certain types of expenditures are not allowable or are limited as to reimbursement. The Company has elected not to use the 10% de minimis indirect cost rate allowed under the Uniform Guidance.
Title: COVID-19 Provider Relief Fund and American Rescue Plan (ARP) Rural Distribution (Assistance Listing No. 93.498) Accounting Policies: The information in this Schedule is presented in accordance with the requirements of the Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). De Minimis Rate Used: N Rate Explanation: The auditee did not use the de minimis cost rate. The Schedule includes $4,921,015 received from the U.S. Department of Health and Human Services (HHS) between July 1, 2021 and December 31, 2021, under the Provider Relief Fund (PRF) program of Assistance Listing No. 93.498. In accordance with guidance from HHS, this amount is presented as Period 4 in the HHS PRF Reporting Portal. This amount was recognized as grant revenue in the Company’s consolidated basic financial statements in the consolidated statement of revenues, expenses and changes in net position for the year ended June 30, 2022. Due to the PRF Reporting Portal requirements, this amount is not the total PRF received and/or recognized by the Company as revenue in the Company’s consolidated basic financial statements for the year ended June 30, 2023. The amount presented on the Schedule for PRF is for the fiscal year ended June 30, 2023. The amount presented reconciles to the PRF information reported to HHS as follows:

Finding Details

Finding No. 2023-001 – Activities Allowed or Unallowed and Allowable Costs – Significant Deficiency in Internal Control Over Compliance. Identification of the federal program: Federal Grantor: United States Department of Health and Human Services (HHS), Health Resources and Services Administration (HRSA). Assistance Listing No.: 93.498, COVID-19 Provider Relief Fund (PRF) and American Rescue Plan (ARP) Rural Distribution. Award Numbers: Not applicable. Award Period of Performance: 07/01/2022–06/30/2023. Criteria or Specific Requirement (Including Statutory, Regulatory, or Other Citation): Section 200.303 of the Uniform Guidance states the following regarding internal control: “The non-Federal entity must: (a) Establish and maintain effective internal control over the Federal award that provides reasonable assurance that the non-Federal entity is managing the Federal award in compliance with Federal statutes, regulations, and the terms and conditions of the Federal award. These internal controls should be in compliance with guidance in “Standards for Internal Control in the Federal Government” issued by the Comptroller General of the United States or the “Internal Control Integrated Framework”, issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).” Specific program terms and conditions established by HHS state that amounts received are to be used to prevent, prepare for, and respond to coronavirus, domestically or internationally, for necessary expenses to reimburse, through grants or other mechanisms, eligible health care providers for health care related expenses or lost revenues that are attributable to coronavirus. Further the terms and conditions state that funds may not be used to reimburse expenses or losses that have been reimbursed from other sources or that other sources are obligated to reimburse and charges to the PRF must be necessary, reasonable, accorded consistent treatment, and conform to the limitations and exclusions of the terms and conditions of the award. Lastly, Providers who received one or more PRF payments exceeding $10,000, in the aggregate per respective reporting period are required to report on their use of funds within the PRF reporting portal. Condition: Management developed a robust process to identify and review the appropriateness of identified amounts of qualifying health care-related expenses incurred throughout the period of availability. During our testing of such controls in place for this program, we were unable to inspect evidence to support the consistent operation of these controls as documentation of the performance of certain controls was not consistently retained. Cause: In certain instances, support that would allow us to inspect evidence as to the consistent operating effectiveness and precision included in the controls was not retained. Questioned costs: None. Context: The total combined qualifying health care-related expenses throughout the period of availability submitted to HRSA’s PRF Reporting Portal amounted to $4,921,015. We selected 60 expenditures totaling $78,461 for testing. We did not identify any instances of noncompliance in the sample we tested. Effect or potential effect: Potential effects include inappropriate amounts of qualifying health care-related expenses that could impact the complete and accurate reporting of such amounts submitted to HRSA’s PRF Reporting Portal and reimbursement for unallowable expenses or for services provided to ineligible patients. Identification as a repeat finding, if applicable: The finding is a repeat finding of Finding 2022-001 in the prior year. Recommendation: Management should retain sufficient appropriate evidence to support the level of precision at which the controls were carried out as designed throughout the fiscal period under audit for amounts qualifying as health care-related expenses in accordance with the terms of the federal program during the period under audit. Views of responsible officials: Management concurs with this finding. See management’s separate Corrective Action Plan.
Finding No. 2023-001 – Activities Allowed or Unallowed and Allowable Costs – Significant Deficiency in Internal Control Over Compliance. Identification of the federal program: Federal Grantor: United States Department of Health and Human Services (HHS), Health Resources and Services Administration (HRSA). Assistance Listing No.: 93.498, COVID-19 Provider Relief Fund (PRF) and American Rescue Plan (ARP) Rural Distribution. Award Numbers: Not applicable. Award Period of Performance: 07/01/2022–06/30/2023. Criteria or Specific Requirement (Including Statutory, Regulatory, or Other Citation): Section 200.303 of the Uniform Guidance states the following regarding internal control: “The non-Federal entity must: (a) Establish and maintain effective internal control over the Federal award that provides reasonable assurance that the non-Federal entity is managing the Federal award in compliance with Federal statutes, regulations, and the terms and conditions of the Federal award. These internal controls should be in compliance with guidance in “Standards for Internal Control in the Federal Government” issued by the Comptroller General of the United States or the “Internal Control Integrated Framework”, issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).” Specific program terms and conditions established by HHS state that amounts received are to be used to prevent, prepare for, and respond to coronavirus, domestically or internationally, for necessary expenses to reimburse, through grants or other mechanisms, eligible health care providers for health care related expenses or lost revenues that are attributable to coronavirus. Further the terms and conditions state that funds may not be used to reimburse expenses or losses that have been reimbursed from other sources or that other sources are obligated to reimburse and charges to the PRF must be necessary, reasonable, accorded consistent treatment, and conform to the limitations and exclusions of the terms and conditions of the award. Lastly, Providers who received one or more PRF payments exceeding $10,000, in the aggregate per respective reporting period are required to report on their use of funds within the PRF reporting portal. Condition: Management developed a robust process to identify and review the appropriateness of identified amounts of qualifying health care-related expenses incurred throughout the period of availability. During our testing of such controls in place for this program, we were unable to inspect evidence to support the consistent operation of these controls as documentation of the performance of certain controls was not consistently retained. Cause: In certain instances, support that would allow us to inspect evidence as to the consistent operating effectiveness and precision included in the controls was not retained. Questioned costs: None. Context: The total combined qualifying health care-related expenses throughout the period of availability submitted to HRSA’s PRF Reporting Portal amounted to $4,921,015. We selected 60 expenditures totaling $78,461 for testing. We did not identify any instances of noncompliance in the sample we tested. Effect or potential effect: Potential effects include inappropriate amounts of qualifying health care-related expenses that could impact the complete and accurate reporting of such amounts submitted to HRSA’s PRF Reporting Portal and reimbursement for unallowable expenses or for services provided to ineligible patients. Identification as a repeat finding, if applicable: The finding is a repeat finding of Finding 2022-001 in the prior year. Recommendation: Management should retain sufficient appropriate evidence to support the level of precision at which the controls were carried out as designed throughout the fiscal period under audit for amounts qualifying as health care-related expenses in accordance with the terms of the federal program during the period under audit. Views of responsible officials: Management concurs with this finding. See management’s separate Corrective Action Plan.